Property Enterprises Development Pte Ltd
⚠️ Moderate Risk
FEI: 3003460042 • Singapore • SINGAPORE
Moderate Risk
FDA Import Risk Assessment
This firm has a moderate history of FDA import refusals. Some attention may be warranted.
Statistics
Score Breakdown
How is this score calculated?
Proprietary Algorithm
- 40% Violation Severity — AI-assessed (1-10)
- 30% Refusal Volume — Logarithmic scale
- 20% Recency — Decays over 5 years
- 10% Frequency — Refusals per year
© ImportRefusal.com Original Analysis
Violation Summary
AGR RX
The article appears to be a prescription drug manufactured in the U.S. and offered for import by other than the manufacturer and reimportation does not appear to have been authorized by the Secretary for use in a medical emergency.
Refusal History
Frequently Asked Questions
What is Property Enterprises Development Pte Ltd's FDA import refusal history?
Property Enterprises Development Pte Ltd (FEI: 3003460042) has 2 FDA import refusal record(s) in our database, spanning from 11/9/2001 to 11/18/2001.
What is an FEI number?
FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. Property Enterprises Development Pte Ltd's FEI number is 3003460042.
What types of violations has Property Enterprises Development Pte Ltd received?
Property Enterprises Development Pte Ltd has been cited for 1 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.
Where does this information about Property Enterprises Development Pte Ltd come from?
All FDA import refusal data for Property Enterprises Development Pte Ltd is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.
Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.